Uncover mechanism & improve functional immune fitness in novel solid tumor immunotherapies
In Cancer Immunology, complex processes such as discovery, lead optimization, and biomarker development for the clinic are all made more complex by the functional interactions stemming from the patient immune cells and the tumor microenvironment. IsoPlexis reveals true functional immune resolution and fitness that uncovers mechanism and reveals actionable insights.
Advancing Cellular Fitness & Precision Medicine with IsoPlexis’ Platform
See Where IsoPlexis Systems are Advancing Cellular Fitness & Precision Medicine in Cancer Immunology
Single-cell Cytokine Profiling of TILS correlates with patient response Anti-PD1 / Anti-CTLA4 therapy in solid tumor
Checkpoint Immunotherapy in Solid Tumor Is Evolving: Advancing Cellular Fitness & Precision Medicine with IsoPlexis’ Platform
Single-Cell Proteomics Reveals Bi-specific Insights in Discovery & Development
Precision Pre-Clinical Development in Solid Tumor: Cancer Immunology
Discover your most potent cells, masked in the bulk & discover the more potent therapies achieving correlative response in vivo
Precision Lead Optimization and Translational Learning
“They have showed that by using single-cell analyses, heterogeneity may actually improve clinical outcomes.”
-Blood Commentary
Predictive Immune Functional Biomarkers in Solid Tumor
“The ability to easily perform single-cell proteomics provides a way to understand the complexity of the cellular response to immunotherapy and then to design and test new therapies to enhance efficacy.”
Explore Resources
See IsoPlexis’ Work Throughout the Combination Therapy Spectrum
Explore by Complex Therapy Interactions
Explore by Each Part of the Cancer Immunity Cycle
Identify the Most Potent Cell Subsets in Your Samples
Our award-winning, single-cell system effortlessly delivers the data you need.
